Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Enterprise Value (2016 - 2026)

Bio Key International (BKYI) has disclosed Enterprise Value for 16 consecutive years, with -$2.0 million as the latest value for Q3 2025.

  • Quarterly Enterprise Value fell 13.25% to -$2.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Sep 2025, down 13.25% year-over-year, with the annual reading at -$437604.0 for FY2024, 14.43% up from the prior year.
  • Enterprise Value hit -$2.0 million in Q3 2025 for Bio Key International, up from -$2.3 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$307086.0 in Q3 2023 to a low of -$14.0 million in Q1 2021.
  • Historically, Enterprise Value has averaged -$3.9 million across 5 years, with a median of -$2.3 million in 2025.
  • Biggest five-year swings in Enterprise Value: tumbled 1095.25% in 2021 and later skyrocketed 88.93% in 2023.
  • Year by year, Enterprise Value stood at -$7.8 million in 2021, then surged by 66.01% to -$2.6 million in 2022, then soared by 80.6% to -$511400.0 in 2023, then rose by 14.43% to -$437604.0 in 2024, then crashed by 366.14% to -$2.0 million in 2025.
  • Business Quant data shows Enterprise Value for BKYI at -$2.0 million in Q3 2025, -$2.3 million in Q2 2025, and -$3.1 million in Q1 2025.